MAVRIK

Main information

  • Trade name:
  • YATES MAVRIK CHEWING & SUCKING INSECT PEST KILLER
  • Pharmaceutical form:
  • Aqueous
  • Units in package:
  • 200mL
  • Class:
  • AgChem
  • Medicine domain:
  • Animals
  • Medicine type:
  • Pesticide
  • Manufactured by:
  • DULUXGROUP

Documents

Localization

  • Available in:
  • YATES MAVRIK CHEWING & SUCKING INSECT PEST KILLER
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • APPLE CROP = APPLE ORCHARD | BRASSICA SPP. OR COLE CROP | BROCCOLI | BRUSSELS SPROUTS | CABBAGE | CAULIFLOWER | CHERRY | GRAPE -
  • Therapeutic area:
  • Group 3A Insecticide
  • Therapeutic indications:
  • APHID | APPLE DIMPLING BUG - C. LIEBKNECHTI | CABBAGE MOTH | CABBAGE WHITE BUTTERFLY | CARMINE MITE | CORN EARWORM | GREEN PEACH APHID | HELICOVERPA SPP. | NATIVE BUDWORM OR BOLLWORM | PLAGUE THRIPS | TOMATO GRUB | CAMPYLOMMA LIVIDA | CORN EARWORM | COTTON BOLLWORM | DIAMONDBACK MOTH | HELIOTHIS | NATIVE BOLLWORM | NATIVE BUDWORM | RED SPIDER MITE | SPIDER MITE | TOBACCO BUDWORM | TOMATO GRUB | TWO-SPOTTED MITE | TWO-SPOTTED SPIDER MITE | YELLOW MIRID
  • Product summary:
  • A broad spectrum synthetic pyrethroid that controls a range of chewing & sucking insects & mites by contact action.DO NOT apply when soil is dry and plants are suffering from moisture stress.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 32819/1009
  • Authorization date:
  • 11-01-2010
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Info

pest

Verified

17-11-2018

Review of the existing maximum residue levels for tau‐fluvalinate according to Article 12 of Regulation (EC) No 396/2005

Review of the existing maximum residue levels for tau‐fluvalinate according to Article 12 of Regulation (EC) No 396/2005

Published on: Fri, 16 Nov 2018 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance tau‐fluvalinate. To assess the occurrence of tau‐fluvalinate residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008 as well as the European authorisations reported by Member St...

Europe - EFSA - European Food Safety Authority Publications

10-1-2019


Orphan designation: glycine, L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-histidine, L-lysine monohydrate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, taurine, Treatment

Orphan designation: glycine, L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-histidine, L-lysine monohydrate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, taurine, Treatment

Orphan designation: glycine, L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-histidine, L-lysine monohydrate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, taurine, Treatment of maple syrup urine disease, 26/10/2018, Positive

Europe - EMA - European Medicines Agency

30-10-2018

EU/3/18/2076 (Orphan Europe S.A.R.L.)

EU/3/18/2076 (Orphan Europe S.A.R.L.)

EU/3/18/2076 (Active substance: Glycine, L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-histidine, L-lysine monohydrate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, taurine) - Orphan designation - Commission Decision (2018)7277 of Tue, 30 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/100/18

Europe -DG Health and Food Safety

2-8-2018

EU/3/18/2041 (Ionis USA Limited)

EU/3/18/2041 (Ionis USA Limited)

EU/3/18/2041 (Active substance: 2'-O-(2-methoxyethyl) antisense oligonucleotide targeting microtubule-associated protein tau pre-mRNA) - Orphan designation - Commission Decision (2018)5273 of Thu, 02 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/050/18

Europe -DG Health and Food Safety

16-5-2018

EU/3/16/1649 (AbbVie Deutschland GmbH and Co. KG)

EU/3/16/1649 (AbbVie Deutschland GmbH and Co. KG)

EU/3/16/1649 (Active substance: Humanised recombinant IgG4 anti-human tau antibody) - Transfer of orphan designation - Commission Decision (2018)3024 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/239/15/T/01

Europe -DG Health and Food Safety